07, 2021 (GLOBE NEWSWIRE) -- HiberCell, a clinical-stage biotechnology company developing therapeutics to address therapeutic resistance, ...
News
- HiberCell To Present New Data on Odetiglucan Plus Pembrolizumab in Ongoing Phase 2 ...
- The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More ... - Benzinga
2021 San Antonio Breast Cancer Symposium Presentations. Gilead Sciences, Inc. (NASDAQ: GILD): Phase 3 data from the ASCENT study of Sacituzumab ...
- Boston Properties, Alexandria lease San Francisco building to biotech - The Business Journals
... are leasing a building under construction — the first phase of a life sciences campus in South San Francisco — to biotech giant Genentech Inc.
- Owners of Whitt Printing building seek demolition, challenging San Antonio historic code | TPR
Bo Lim, owner, gets choked up talking about her grandfather coming to San Antonio in search of a better life. He started the family's first ...
- San Antonio virus-hunters search for the omicron variant
Scientists say it's only a matter of time before omicron is found in San Antonio.